Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Cleveland Biolabs (CBLI)

Cleveland Biolabs (CBLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Genome Protection Announces Publication of the Next Generation Deimmunized TLR5 Agonist, GP532 AccessWire - Wed Apr 14, 2021

The substantially improved pharmacological profile of GP532 opens new opportunities for broader therapeutic applications of this class of pharmaceuticals BUFFALO, NY / ACCESSWIRE / April 14, 2021 / Genome...

CBLI : 3.17 (-7.31%)
Cleveland BioLabs, Inc. Announces Closing of $14 Million Registered Direct Offering of Common Stock AccessWire - Tue Feb 23, 2021

BUFFALO, NY / ACCESSWIRE / February 23, 2021 / Cleveland BioLabs, Inc. (NASDAQ:CBLI), today announced that it has closed its previously announced registered direct offering for the issuance and sale of...

CBLI : 3.17 (-7.31%)
Cleveland BioLabs, Inc. Announces $14 Million Registered Direct Offering of Common Stock AccessWire - Fri Feb 19, 2021

BUFFALO, NY / ACCESSWIRE / February 19, 2021 / Cleveland BioLabs, Inc. (NASDAQ:CBLI), today announced that it has entered into definitive agreements with certain healthcare-focused and institutional investors...

CBLI : 3.17 (-7.31%)
Cleveland BioLabs, Inc. Files Registration Statement on Form S-4 for Proposed Merger with Cytocom Inc. AccessWire - Wed Feb 17, 2021

Combined public entity to develop and commercialize next-generation immune therapies that address unmet needs in oncology, infectious disease, inflammation and auto-immune-mediated conditions FORT COLLINS,...

CBLI : 3.17 (-7.31%)
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigations of CBLI, NEBC, THCB, and FTOC Mergers Globe NewsWire - Tue Feb 16, 2021

WILMINGTON, Del., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating:

CBLI : 3.17 (-7.31%)
NEBC : 10.99 (+10.23%)
THCB : 10.00 (-1.96%)
FTOC : 10.76 (+2.38%)
ALERT: Halper Sadeh LLP Investigates CPAH, CBLI, QEP, SNCA; Shareholders Are Encouraged to Contact the Firm Globe NewsWire - Tue Jan 5, 2021

NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

CPAH : 3.48 (+0.43%)
CBLI : 3.17 (-7.31%)
QEP : 4.08 (-4.45%)
SNCA : 9.9600 (-1.19%)
Lifshitz Law Firm, P.C. Announces Investigation of CBMG, CBLI, WORK, and UROV AccessWire - Sun Jan 3, 2021

NEW YORK, NY / ACCESSWIRE / January 3, 2021 / Lifshitz Law Firm, P.C.: Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties...

CBMG : 19.75 (unch)
CBLI : 3.17 (-7.31%)
WORK : 45.20 (+0.09%)
UROV : 16.24 (+0.06%)
MERGER INVESTIGATION ALERT: Halper Sadeh LLP Encourages NK, PRGX, CBLI, and IPHI Shareholders to Contact the Firm AccessWire - Sat Jan 2, 2021

NEW YORK, NY / ACCESSWIRE / January 2, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: NantKwest, Inc. (NASDAQ:NK) concerning potential...

NK : 32.49 (+14.89%)
PRGX : 7.71 (+0.13%)
CBLI : 3.17 (-7.31%)
IPHI : 172.27 (-1.08%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies – ALXN, ELY, CLCT, CBLI AccessWire - Sat Dec 19, 2020

NEW YORK, NY / ACCESSWIRE / December 19, 2020 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) concerning...

ELY : 21.33 (-2.82%)
ALXN : 182.50 (+1.70%)
CLCT : 91.92 (+0.04%)
CBLI : 3.17 (-7.31%)
Lifshitz Law Firm, P.C. Announces Investigation of CBMG, CBLI, COP, and EIGI AccessWire - Thu Dec 3, 2020

NEW YORK, NY / ACCESSWIRE / December 3, 2020 /Lifshitz Law Firm, P.C.: Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties...

CBMG : 19.75 (unch)
CBLI : 3.17 (-7.31%)
COP : 107.84 (-1.55%)
EIGI : 9.49 (unch)

Barchart Exclusives

Thanks to Wall Street, Novo Nordisk Stock is Now a Buy Barchart - Sat Nov 2, 10:15AM CDT
Novo Nordisk has lost about a quarter of its value since the end of June. Meanwhile, indications are that its diabetes and weight-loss drugs may be useful in fighting cardiovascular disease, arthritis, opioid and alcohol addiction, and Alzheimer's. Novo remains a leader in the sector, and is trading at a valuation a third cheaper than competitor, Eli Lilly. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot